Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | CASP3 | P42574 | 1/20 | 0.62 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.62 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.62 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 3/20 | 0.55 |
| ▸ | ESR1 | P03372 | 5/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.55 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14399793 | 1.00 | MAPT (0.62) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL4063764 | 1.00 | MAPT (0.62) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL14503286 | 0.95 | MAPT (0.58) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL30354554 | 0.93 | THRB (0.62) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL10633416 | 0.93 | THRB (0.62) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL17150360 | 0.92 | MAPT (0.54) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL11116193 | 0.91 | SMN1; SMN2 (0.58) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL26040043 | 0.90 | NPC1 (0.58) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL2865085 | 0.89 | LMNA (0.60) | MAPTSMN1; SMN2NPC1RAB9ACASP3 | |
| SCHEMBL28921724 | 0.89 | LMNA (0.60) | MAPTSMN1; SMN2NPC1RAB9ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8634046-B2 | Optical element having an alignment layer for an optical anisotropic body | DAI NIPPON PRINTING CO., LTD. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20070128430-A1 | Retardation layer forming coating solution, retardation optical product, and manufacturing method of retardation optical product | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | MAPT 3954/4885SMN1; SMN2 2743/4885NPC1 3547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.